baber/WOPTO huggingface dataset:
Patent IL-154180-A0 (IL)
Title: System and method
IPC: G01N27/447
Filed: 2001-07-20
Abstract: An analysis system for and method of enabling determination of the velocities of migrating objects and also classifying migrating objects into groups having a common constraint. In one aspect the present invention provides an analysis system for and method of enabling determination of the velocities of migrating objects, the system comprising: a space-time map generator for generating a space-time map of points representative of the signal peaks of signals detected at a plurality of spaced positions; and a vertex finder for identifying at least one vertex from the space-time map, with a single vertex being identified for each group of objects having a common constraint and the velocities of the objects being determinable from the sets of points in the space-time map corresponding to the respective objects as fitted to the respective vertex. In another aspect the present invention provides an analysis system for classifying migrating objects into groups each having a common constraint, the system comprising: a space-time map generator for generating a space-time map of points representative of the signal peaks of signals detected at a plurality of spaced positions; and a vertex finder for identifying at least one vertex from the space-time map, with a single vertex being identified for each group of objects having a common constraint.
Patent IL-173159-A0 (IL)
Title: Pharmaceutical composition comprising i.a. vitamin c, magnesium, green tea extract for retarding cardiovascular diseases
IPC: A61K31/353
Filed: 2006-01-15
Abstract: The present invention provides pharmaceutical compositions comprising lysine, proline, arginine, vitamin C, magnesium, green tea extract, N-acetylcysteine, selenium, copper, manganese and one pharmaceutical acceptable component selected from the group consisting of a carrier, a diluent, and an excipient, wherein the pharmaceutical composition without the acceptable component contains 7-9 wt % magnesium, 20-30 wt % ascorbic acid and 11-25 wt % green tea extract A method of treting cardio-vascular diseases using the pharmaceutical compositions are also disclosed, more preferably for the treatment of post-menopausal women.
Patent IL-179635-A0 (IL)
Title: Human anti-kir antibodies
Filed: 2006-11-27
Abstract: PROBLEM TO BE SOLVED: To provide compositions and methods for controlling immune responses of subjects, and more specifically, to provide a human antibody and human monoclonal antibody which control natural killer cell activity and admit potentiation of cytotoxicity of natural killer cells in mammalian subjects.SOLUTION: The antibody includes antigen binding characteristics similar to antigen binding characteristics of 1-7F9 or 1-4F1 that is a monoclonal antibody of cross-reactivity with KIR2DL1, -2 and -3. There are also provided fragments and derivatives of the antibody; a pharmaceutical composition including the antibody, the fragments and derivatives of the antibody; and the use thereof, especially, the use thereof in treatments to increase natural killer cell activities or cytotoxicity in subjects.
Patent IL-182040-A0 (IL)
Title: Process for good packaging, namely food stuffs, packaging and kits for their realization
Filed: 2007-03-20
Abstract: A process for carrying out a packaging for food stuffs, such as hazelnuts, dried fruits, or powdered milk, packaged in bulk, comprises the steps of: —provision of a big bag container (2), —carrying out a filling of the above said product (P), into the big bag container (2.), —provision of a seal enclosure (3) susceptible of containing the big bag container (2) with the above said filling of product (P) therein, and- sealing the enclosure (3) containing the big bag container (2), with the above said filling of product (P) therein, a sub atmospheric pressure. level. Preferably, a protective inert gas, such as nitrogen, is inserted into the enclosure (3) containing the big bag container (2).
Patent IL-202400-A0 (IL)
Title: Pharmaceutical compositions for the treatment of chronic heart failure comprising pyrazolopyrimidinone derivative compound
Filed: 2009-11-29
Abstract: Disclosed herein is a therapeutic agent for chronic heart failure comprising, as an effective ingredient, 5-[2-propyloxy-5-(1-methyl-2-pyrrolidinyl-ethylamidosulfonyl)phenyl]-1-methyl-propyl-1,6-dihydro-7H-pyrazolo(4,3-d)pyrimidine-7-one. The compound inhibits phosphodiesterase-5 (PDE-5), which catalyzes the intracellular degradation of cyclic guanosine monophosphatase (cGMP), thereby mitigating several signs of chronic heart failure, that is, thereby preventing left ventricular dilatation, decreasing ventricular wall thinning, lowering elevated cardiac and circulating levels of atrial natriuretic peptide (ANP), and inhibiting ventricular fibrosis. Also, the compound has advantages in that it reaches the maximal plasma level in a short time, has an in vivo half-life longer than conventional PDE-5 inhibitors, allowing decreased administration frequency, and has fewer side effects, thus ensuring safety. Thus, the compound is useful as a therapeutic agent for chronic heart failure.
Patent IL-211051-A0 (IL)
Title: Cell disruption of plant and animal raw materials by a combination of atomization processes with decompression processes for selective extraction and separation of intracellular valuable substances
Filed: 2011-02-03
Abstract: A method for cell disruption of biogenic suspended raw materials by means of a combination of pressurization, atomization and decompression with a subsequent selective extraction and separation of cellular valuable substances includes at least one reservoir cubicle serving as reservoir for a suspension composed of biogenic raw material and at least another reservoir cubicle utilized as reservoir for a solvent. A cellular extract is produced in one unit for cell disruption, and is subsequently flown through by a gas in an extraction stage. The gas burdened with cellular valuable substances is separated from the cellular valuable substances in a separation stage by lowering the pressure. The suspension includes biogenic raw material pressurized to a pressure of 100-2500 bar by a device for pressure boosting. The solvent is pressurized to a pressure of 100-2500 bar by a device for pressure boosting. The solvent and the suspension are brought together in one line at a pressure of 100-2500 bar and mixed to a solution mixture which is atomized through at least one jet at a pressure of 100 to 2500 bar and a temperature of 10 to 90° C. into a cubicle with a lower pressure.
Patent RO-131335-A0 (RO)
Title: Textile composite material for manufacturing heat-pressed items, process and installation for manufacturing the same
Inventor: FILIP IOAN
IPC: D04H18/02
Filed: 2016-03-08
Abstract: The invention relates to a composite material for manufacturing heat-pressed items, to a process and an installation for manufacturing the same as non-woven material. The claimed material comprises a mixture of polypropylene fibres with a length of 4...60 mm and fineness of 7...16 DEN, in a ratio ranging between 40 and 50% of the total mixture weight, with vegetable fibres at a fibre fineness of about 70...80 DEN and a fibre length ranging between 5 and 100 mm, in a ratio ranging between 60 and 50% of the total mixture weight. The process for manufacturing the claimed composite material consists in taking over and dosing the components, followed by a mixing and a coarse defibering thereof and then by a fine mixing with a four-chamber mixer and an opening of natural fibers to a fineness of 70...80 DEN, followed by reinforcement of fibers and, finally, by rolling the resulting fiber sheet as a roll. The installation for manufacturing the claimed composite material has a modular structure, comprising two modules (1 and 2) for feeding the components, two modules (3 and 4) for weighing and dosing the components, a primary mixing and coarse defibering module (5), a module (7) for fine mixing and fibre opening, an interweaving module (8) and a module (9) for pulling and winding.
Patent RO-137420-A0 (RO)
Title: Methods for identification and detection of oral and extraoral halitosis and correlation panels
Inventor: CALENIC BOGDAN
IPC: G01N33/497
Filed: 2022-12-21
Abstract: The invention relates to a method for the identification and detection of halitosis by methods of detection, analysis and correlation between volatile compounds present in the air exhaled by a patient and correlation panels, the method being used in the medical field for examining the concentration of volatile compounds and correlating said data with various types of existing diseases. According to the invention, the method has the following steps: a. collecting a volume of exhaled air from a patient, b. determining the levels of volatile compounds in the volume of air by using chromatography technologies, c. identifying the set of volatile compounds specific to different types of halitosis, d. associating the obtained results with the results of the studies carried out on a group of patients, e. correlating the concentrations of detected volatile compounds (methyl mercaptan, hydrogen sulphide or dimethyl sulphide) with the types of oral or extra-oral halitosis, followed by the correlation of the data obtained from the analysis of exhaled air samples with the variables specific to each condition. The claimed volatile compound panels which provide the detection of the halitosis of oral cause for the following conditions: gingivitis, juvenile paradontitis, deep paradontitis and superficial paradontitis. The claimed volatile compound panels which provide the detection of the halitosis of extraoral cause for the following conditions: gastritis. ulcer, diabetes mellitus, skin ulcerations and squamous cell carcinoma.
Patent AU-2003900387-A0 (AU)
Title: Process for nickel and cobalt extraction from laterite ores
IPC: C22B1/02
Filed: 2003-01-30
Abstract: A method for the recovery of nickel and cobalt from nickel and cobalt containing laterite ores, said method comprising: a) roasting feed ore in a reducing atmosphere in a rotary kiln to selectively reduce the nickel and cobalt, wherein either no, or less than 2.5% w/w reductant is added to the feed ore prior to roasting; b) leaching the reduced ore with an aerated ammoniacal ammonium carbonate solution to extract the nickel and cobalt into a leach solution; and c) separating the leach solution from the ore tailings and recovering the nickel and cobalt by a process selected from ammoniacal solvent extraction, precipitation techniques or ion exchange.
Patent CU-21922-A1 (CU)
Title: Dispositivo para la medición simultánea de las curvas de análisis térmico diferencial y de análisis térmico dieléctrico
Inventor: ROQUE MALHERBE ROLANDO MARCOS
IPC: G01N25/02
Filed: 1987-06-16
Abstract: Esta invención se relaciona con la rama de la técnica de equipos e instrumentos científicos. El objetivo fundamental de este dispositivo es lograr los registros simultáneos de las curvas de Análisis Térmico Diferencial y Análisis Térmico Dieléctrico. La invención consta de dos crisoles cerámicos para ATD, introduciéndosele a cada uno un capacitor cilíndrico construido con láminas de Níquel conectadas a un circuito electrónico de medición dieléctrica. Este dispositivo se montó en un analizador térmico diferencial, permitiendo realizar registros simultáneos de ambos análisis. Los campos de aplicación son: Química analítica (análisis de pureza y estabilidad de compuestos, análisis de sustancias sólidas, etc.); Química inorgánica (minerales, cerámicas, metales, aleaciones, etc.) y Química orgánica (drogas, plásticos, explosivos, combustibles, etc.), entre otros.
Patent MA-20235-A1 (MA)
IPC: A01N37/52
Filed: 1984-09-21
Abstract: The compounds of the formula I    <IMAGE>  (I)  in which R1 to R5 denote hydrogen; alkyl, alkoxy, alkylmercapto, alkylsulfinyl, alkylsulfonyl, alkylsulfonyloxy each of which can be halogenated, halogen or nitro, R6 to R10 denote hydrogen; alkyl, alkoxy, alkenyloxy, alkylmercapto, alkenylmercapto, alkylsulfonyl or C3-hydroxyalkyl each of which can be halogenated, (substituted) benzyloxy, alkoxycarbonyl or NRR', and R7 and R8 together can form a (substituted) alkylenedioxy radical, X denotes OR11 in which R11 denotes optionally halogenated alkyl, cycloalkyl, alkenyl or alkynyl or optionally halogenated benzyl, or SR12 in which R12 denotes alkyl or benzyl each of which can be halogenated, and Y denotes oxygen or sulfur, subject to the proviso that, if R1 and R5 both denote fluorine and R2, R3 and R4 denote hydrogen, the radicals R6 to R10 must not each represent halogenated (C1-C6)-alkyl or halogen, possess an intense action against a broad spectrum of harmful insects.
Patent MA-27120-A1 (MA)
Title: Des pyrrolecarboxanilides fusionnes, une nouvelle classe de gaba (acide aminobutyrique) pour tissus recepteurs de cerveau
Inventor: ALBAUGH PAMELA
IPC: C07D471/04
Filed: 1997-07-16
Abstract: L'invention actuelle englobe les structure de la formule: ou les sels non-toxiques acceptables phannaceutiquement en découlant oé: W représente du phényle substituée ou non-substitué; X est de l'hydrogène, hydroxy ou alkyle léger; T est de l'hydrogène, halogène, hydroxy, nitro, amino ou alkyle; R3 est de l'hydrogène ou un groupe organique; R4 est de l'hydrogène ou un substituant organique substitué ou non; R5 et R6 représentent des substituants organiques et inorganiques; et n est 1, 2,3 ou 4, dont les composés sont des agonistes, antagonistes ou agonistes inverses très sélectifs pour les récepteurs du cerveau GABAa ou des prodrogues d'agonistes, d'antagonistes ou d'agonistes inverses pour les récepteurs du cerveau GABAa. Ces composés sont utiles pour le diagnostic et le traitement de l'anxiété, des troubles du sommeil et épileptique, des surdoses de drogues au benzodiazépine et pour améliorer la mémoire.
Patent MA-25944-A1 (MA)
Inventor: ANA MARIA MENDES CERDEIRA
IPC: A61P25/24
Filed: 2002-06-03
Abstract: The object of the present invention is the obtention of prolonged release matricial pharmaceutical formulations of pirindol hydrochloride that have stable and similar dissolution profiles in mediums of different pH values (1.2<pH<8.0). The present invention consists in the obtention of pharmaceutical formulations by the dry mixing and/or granulation process of the pirlindol hydrochloride with alginic acid derivative polymers (for example sodium alginate, calcium alginate) and commonly used excipients in the pharmaceutical technology. Further, the present invention consists in the obtention of pharmaceutical formulations composed by a pirlindol hydrochloride and sodium alginate matrix, stable during the storage period and that show good dissolution, absorption properties and consequently a adequate bioavailability when orally administrated. <IMAGE>
Patent MA-26136-A1 (MA)
Inventor: JACOB MAURICE
IPC: A61K9/16
Filed: 2004-02-12
Abstract: The invention concerns the formulation and method of fabricating rapid dispersion spheroids which can be heavily charged with active substances. These spheroids are formulated using at least one active substance, specifically a solution of vegetable origin, absorbed and/or adsorbed on a dry technological mixture with a slightly substituted hydroxypropylated cellulose ether base at the level of core groups beta-O-glucopyranosil, preferably characterized by having a substitution rate of about 11% and a water soluble fractional percentage of about 4.29%. The spheroids are obtained by an extrusion and spheronization process. This invention is of interest in the fields of health, hygiene, dietetics, cosmetology, nutrition, and agriculture; it may concern humans or animals.
Patent MA-28144-A1 (MA)
Title: Nouveau procede de synthese du perindopril et de ses sels pharmaceutiquement acceptables
Inventor: THIERRY DUBUFFET
IPC: C07C309/73
Filed: 2006-05-02
Abstract: NOUVEAU PROCEDE DE SYNTHESE DU PERINDOPRIL ET DE SES SELS PHARMACEUTIQUEMENT ACCEPTABLES Procédé de synthèse du perindopril de formule (I):  et de ses sels pharmaceutiquement acceptables.
Patent MA-28305-A1 (MA)
Title: Formulation a compression directe et procede correspondant
Inventor: KOWALSKI JAMES
IPC: A61K47/00
Filed: 2006-07-24
Abstract: FORMULATION ET PROCESSUS DE COMPRESSION DIRECTE L'inhibiteur de dipeptidylpeptidase IV (appelé ici DPP-IV) qui peut être à 98,5-100% pur est un médicament à haute dose pouvant être comprimé avec des excipients spécifiques sous des formes de dosage solides, telles que des comprimés et des capsules ayant une dureté, une capacité de désintégration souhaitées et des caractéristiques de dissolution acceptables. Le DPP-IV n'est pas compressible de manière inhérente et présente donc des problèmes de préparations. Les excipients utilisés dans la préparation améliorent les propriétés d'écoulement et de compactage du médicament et du mélange à comprimer. Un écoulement optimal contribue à un remplissage uniforme de la matrice et à un contrôle du poids. Le liant utilisé assure des propriétés cohésives suffisantes pour permettre au DPP-IV d'être comprimé en utilisant le procédé de compression directe. Les comprimés produits offrent un profil de dissolution in vitro acceptable.
Patent MA-39179-A1 (MA)
Title: Complexes de cuivre-ammonium et complexes de cuivre-zinc-ammonium solubilisés en milieu acide, compositions, préparations, procédés et utilisations
Inventor: HALL TONY JOHN
IPC: A01N59/20
Filed: 2016-07-11
Abstract: La présente invention concerne une composition antimicrobienne contenant un complexe de cuivre-ammonium ou de cuivre-zinc-ammonium solubilisé en milieu acide qui est efficace contre les microorganismes tels que les bactéries nosocomiales ou environnementales, les champignons, les virus, et analogues. La composition antimicrobienne peut être utilisée dans la préparation d'un médicament destiné à traiter les microbes ou une infection microbienne, et peut contenir un support pour former une crème, un savon, un produit lavant, une pulvérisation, un pansement, un produit nettoyant, un produit cosmétique, un médicament topique ou un autre produit antimicrobien.
Patent MA-49232-A1 (MA)
Title: Charbon actif préparé à base du noyau du nbeg ziziphus lotus (sidr) et son procédé de fabrication
Inventor: TOUZANI IBRAHIM
IPC: B01J20/30
Filed: 2020-03-13
Abstract: La presente invention concerne un charbon actif prepare a base d’un nouveau biomateriau et son precede de facbrication base sur l’activation chimique/thermique du noyau du nbeg ziziphus lotus (sidr) et son application comme un nouveau support d’adsorption pour le traitement des eaux usees, la purification du biogaz, abattement des elements de trace metalliques, la reduction de la charge organique et microbienne.
Patent MA-58503-A1 (MA)
Title: Extrait du tourteau des graines de moringa peregrina, son procédé d'obtention et son utilisation dans des compositions cosmétiques ou nutricosmétiques
Inventor: DODINET ELIZABETH
IPC: A61Q19/00
Filed: 2021-05-21
Abstract: L'invention concerne un extrait du tourteau des graines de moringa peregrina comprenant majoritairement un hydrolysat peptidique et un procédé d'obtention de l'extrait. Elle concerne également les compositions cosmétiques ou nutricosmétiques comprenant ledit extrait et l'utilisation des dites compositions pour améliorer l'aspect de la peau, des muqueuses ou des phanères, prévenir et/ou lutter contre la sècheresse de la peau et des muqueuses, prévenir et/ou à lutter contre les signes cutanés du vieillissement et/ou du photo-vieillissement, favoriser le blanchiment de la peau et favoriser l'amincissement.
Patent UY-28182-A1 (UY)
Title: Uso de dipiridamol en combinación con ácido acetilsalicílico y un antagonista de angiotensina ii para la prevención de accidente cerebrovascular
Inventor: GILBERT JAMES C
IPC: A61K31/41
Filed: 2004-02-10
Abstract: Esta invención se refiere a un método para prevenir el accidente cerebrovascular o para reducir el riesgo de accidente cerebrovascular en un paciente que requiere tratamiento, especialmente en un paciente de riesgo para un accidente cerebrovascular o para un accidente cerebrovascular secundario, usando dipiridamol en combinación con ácido acetilsalicílico (ASA) y un antagonista de angiotenasina II, composiciones farmacéuticas correspondientes, y al uso de dipiridamol para la fabricación de una composición farmacéutica correspondiente que comprende una combinación de dipiridamol, ácido acetilisalicílico y un antagonista de angiotensina II.
Patent UY-30084-A1 (UY)
Title: Compuestos de piperazina con accion herbicida
Inventor: EHRHARDT DR THOMAS
IPC: C07D417/02
Filed: 2007-01-05
Abstract: La presente invencinn se refiere al uso de compuestos de piperazina de fnrmula I o de las sales aceptables para uso agrecola de compuestos de piperazina de fnrmula I como herbicidas, donde las variables en f`nrmula I presentan los significados indicados en las reivindicaciones y la descripcinn. La invencinn tambicn se refiere a medios, que ademrs de los adyuvantes usuales para la formulacinn de herbicidas, contienen compuestos de piperazina de fnrmula I o las sales aceptables para uso agrecola de I, ase como un procedimiento para la preparación de estos medios. La invencinn se refiere ademrs a determinados compuestos de piperazina de Fnrmula I, a un procedimiento para combatir el crecimiento indeseado de plantas, en el que se trata las plantas, sus semilla y/o su hrbitat con al menos un compueto de piperazina de f`nrmula I.
Patent UY-30198-A1 (UY)
Title: Dominios kunitz quiméricos y su uso
Inventor: LENZ DR JUERGEN
IPC: C07K14/00
Filed: 2007-03-08
Abstract: La presente invencion se refiere a quimeras del dominio 1 del inhibidor del factor tisular humano con dominios de Kunitz naturales y no naturales, y su preparacion y uso.
Patent UY-31129-A1 (UY)
Title: Disolución directa del docetaxel en un disolvente en polisorbato 80
Inventor: MOSTAFA NAKACH
IPC: A61K9/00
Filed: 2008-06-06
Abstract: Se refiere a la solubilización del docetaxel en un disolvente orgánico, a su mezcla con polisorbato 80 y a la evaporación del disolvente.
Patent AT-524513-A1 (AT)
Title: Kupplung für Zugkräfte
Inventor: HERWIG DÜRNBERGER
IPC: B61B11/00
Filed: 2021-03-26
Abstract: Die Erfindung betrifft eine lösbare Kupplung zwischen einem Anschlussteil (1) und einer Haltebaugruppe (2) für das Übertragen einer Zugkraft, wobei der Anschlussteil (1) einen teilkugelförmigen Fortsatz (6) aufweist, und die Haltebaugruppe (2) mehrere Backen (8) umfasst, welche um eine Schwenkachse (10) schwenkbar sind, und ein Zangenmaul (11) begrenzen, in welches der teilkugelförmige Fortsatz (6) einbringbar ist, und darin durch Schwenken der Backen (8) einklemmbar ist. Die Backen (8) weisen an der Außenseite der Öffnung des Zangenmaules (11) eine Einlaufschräge (18) auf. Ein Blockierteil (9, 19) ist geführt parallel zur Richtung der zu übertragenden Zugkraft verschiebbar; je nach Stellung ragt er in die Bewegungsbahn von Teilen der Backen (8) bei deren öffnender Schwenkbewegung oder nicht.
Patent DZ-3473-A1 (DZ)
Inventor: GORISSEN HENRICUS R M
IPC: A61K9/22
Filed: 2001-09-28
Granted: 2002-04-04
Abstract: The present invention is related to an optionally coated pharmaceutical hydrophilic gel forming matrix formulation comprising one or more active substances and having a prolonged release of said one or more active substances upon exposure to gastrointestinal fluids, characterized in that said release is substantially ion-strength independent. The invention is further related to a method of preparing this formulation which can be used in the administration of active substances for the treatment of a large number of disorders.
Patent ES-164803-A1 (ES)
Title: UN DISPOSITIVO PARA IMPRESIoN DE FORMA CILiNDRICA
Filed: 1944-01-28
Abstract: Un dispositivo para impresión destinado a máquinas rotativas de impresión caracterizado por el hecho de que la forma de impresión consta de una plancha curvada en forma cilíndrica y cuyos extremos o bordes quedan unidos canto contra canto.